These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8627342)

  • 1. Expression of growth factors and growth factor receptors in capillary hemangioblastoma.
    Böhling T; Hatva E; Kujala M; Claesson-Welsh L; Alitalo K; Haltia M
    J Neuropathol Exp Neurol; 1996 May; 55(5):522-7. PubMed ID: 8627342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Marti HH; Plate KH
    Blood; 1998 Nov; 92(9):3388-93. PubMed ID: 9787178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology, genetics and cell biology of hemangioblastomas.
    Wizigmann-Voos S; Plate KH
    Histol Histopathol; 1996 Oct; 11(4):1049-61. PubMed ID: 8930647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.
    Stratmann R; Krieg M; Haas R; Plate KH
    J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.
    Wizigmann-Voos S; Breier G; Risau W; Plate KH
    Cancer Res; 1995 Mar; 55(6):1358-64. PubMed ID: 7533661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
    Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL
    Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial cells by inactivation of VHL gene direct angiogenesis, not vasculogenesis via Twist1 accumulation associated with hemangioblastoma neovascularization.
    Wang Y; Chen DQ; Chen MY; Ji KY; Ma DX; Zhou LF
    Sci Rep; 2017 Jul; 7(1):5463. PubMed ID: 28710479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological study of vascular endothelial growth factor (VEGF), p53, and proliferative potential in familial von Hippel-Lindau disease and sporadic hemangioblastomas.
    Miyagami M; Katayama Y; Nakamura S
    Brain Tumor Pathol; 2000; 17(3):111-20. PubMed ID: 11310918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch receptor and effector expression in von Hippel-Lindau disease-associated central nervous system hemangioblastomas.
    Merrill MJ; Edwards NA; Lonser RR
    J Neurosurg; 2011 Sep; 115(3):512-7. PubMed ID: 21663414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of angiogenic signaling pathways in hemangioblastoma.
    Pierscianek D; Wolf S; Keyvani K; El Hindy N; Stein KP; Sandalcioglu IE; Sure U; Mueller O; Zhu Y
    Neuropathology; 2017 Feb; 37(1):3-11. PubMed ID: 27388534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of VHL tumourigenesis in nerve root tissue.
    Vortmeyer AO; Tran MG; Zeng W; Gläsker S; Riley C; Tsokos M; Ikejiri B; Merrill MJ; Raffeld M; Zhuang Z; Lonser RR; Maxwell PH; Oldfield EH
    J Pathol; 2006 Nov; 210(3):374-82. PubMed ID: 16981244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system capillary haemangioblastoma: the pathologist's viewpoint.
    Hussein MR
    Int J Exp Pathol; 2007 Oct; 88(5):311-24. PubMed ID: 17877533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
    Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
    Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas.
    Hatva E; Böhling T; Jääskeläinen J; Persico MG; Haltia M; Alitalo K
    Am J Pathol; 1996 Mar; 148(3):763-75. PubMed ID: 8774132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression and activation of epidermal growth factor receptor in hemangioblastomas.
    Chen GJ; Karajannis MA; Newcomb EW; Zagzag D
    J Neurooncol; 2010 Sep; 99(2):195-200. PubMed ID: 20730556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma.
    Hoang MP; Amirkhan RH
    Am J Surg Pathol; 2003 Aug; 27(8):1152-6. PubMed ID: 12883249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
    Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factor in cerebellar hemangioblastomas does not correlate with tumor angiogenesis.
    Vaquero J; Zurita M; Coca S; Salas C; Oya S
    Cancer Lett; 1998 Oct; 132(1-2):213-7. PubMed ID: 10397476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.
    Wanebo JE; Lonser RR; Glenn GM; Oldfield EH
    J Neurosurg; 2003 Jan; 98(1):82-94. PubMed ID: 12546356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin receptor 2A expression in von Hippel-Lindau-related hemangioblastomas.
    Ahmad S; Muhlebner A; Snijders TJ; de Leng WW; Seute T; van Leeuwaarde RS
    Cancer; 2024 Oct; 130(20):3473-3479. PubMed ID: 38824656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.